Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/22 07:15 | 5/12/22 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | P | 6,318 | 28.74 | 0 | 220 | 15 | 1,668 | I | ||||||||||||||
3/18/22 19:34 | 3/16/22 | NTRA | Health | Health | Medical Laboratories | Botha Roelof | CA | D | P | 5,005 | 32.72 | 0 | 153 | 13 | 1,292 | I | |||||||||||||||
7/26/21 18:11 | 7/22/21 | NTRA | Health | Health | Medical Laboratories | Healy James | TX | D | P | 271 | 113.00 | 0 | 2 | 0 | 3,135 | I | |||||||||||||||
6/21/16 20:07 | 6/19/16 | NTRA | Health | Health | Medical Laboratories | Steuart John | MD | D | P | 1,000 | 11.94 | 4 | 84 | New | 84 | D | 6 | 26 | 16 | -16 | -1 | 0 | 5 | 12 | 13 | -11 | 3 | ||||
6/21/16 20:07 | 6/19/16 | NTRA | Health | Health | Medical Laboratories | Botha Roelof | CA | DT | P | 10,000 | 11.94 | 4 | 838 | 11 | 8,582 | I | 6 | 26 | 16 | -16 | -1 | 0 | 5 | 12 | 13 | -11 | 3 | ||||
7/9/15 16:20 | 7/8/15 | NTRA | Health | Health | Medical Laboratories | Healy James | CA | D | P.d | 6,300 | 18.00 | 9 | 350 | 13 | 3,101 | I | 19 | 2 | -3 | -16 | -56 | -50 | -42 | ||||||||
7/7/15 21:57 | 7/2/15 | NTRA | Health | Health | Medical Laboratories | Healy James | CA | D | P | 9,124 | 22.81 | 9 | 400 | New | 400 | I | -2 | -4 | -22 | -56 | -53 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |